Atlas Trials

RCT on Intralesional Rituximab Injection Versus ISRT in Ocular Adnexal MALT Lymphoma

Clinical trial NCT06190301 · RECRUITING

Trial details

NCT number
NCT06190301
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Primary Ocular Adnexal MALT Lymphoma
Start date
2023-12-20
Primary completion
2029-12-31
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.